title: Cyclin-dependent kinases (cdks) and the DNA damage response: rationale for cdk inhibitor-chemotherapy combinations as an anticancer strategy for solid tumors.
authors.affiliation: Dana-Farber Cancer Institute, Department of Medical Oncology, Boston, MA 02215, USA.
authors.forename: Neil
authors.initials: N
authors.lastname: Johnson
authors.forename: Geoffrey I
authors.initials: GI
authors.lastname: Shapiro